Hindricks, G. et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373–498 (2021).

Article  PubMed  Google Scholar 

Ruff, C. T. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383, 955–962 (2014).

Article  CAS  PubMed  Google Scholar 

Freedman, B. et al. Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nat. Rev. Cardiol. 14, 701–714 (2017).

Article  PubMed  Google Scholar 

Lip, G. Y. H. et al. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. Europace 25, euad226 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Vitolo, M. et al. Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. Eur. J. Intern. Med. 92, 100–106 (2021).

Article  PubMed  Google Scholar 

Healey, J. S. et al. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366, 120–129 (2012).

Article  CAS  PubMed  Google Scholar 

Singer, D. E., Ziegler, P. D., Koehler, J. L., Sarkar, S. & Passman, R. S. Temporal association between episodes of atrial fibrillation and risk of ischemic stroke. JAMA Cardiol. 6, 1364–1369 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Kirchhof, P. et al. Anticoagulation with edoxaban in patients with atrial high-rate episodes. N. Engl. J. Med. 389, 1167–1179 (2023).

Article  CAS  PubMed  Google Scholar 

Healey, J. S. et al. Apixaban for stroke prevention in subclinical atrial fibrillation. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2310234 (2023).

Van Gelder, I. C. et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur. Heart J. 38, 1339–1344 (2017).

Article  PubMed  Google Scholar 

Becher, N. et al. Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hours. Eur. Heart J. https://doi.org/10.1093/eurheartj/ehad771 (2023).